Zydus Lifesciences shares jump 6% as May 19 buyback plan and 166 million Assertio deal surface

Published on 14 May 2026

Board will meet May 19, but the bigger surprise is the deal size

Zydus Lifesciences shares surged nearly 6% after the company said its board will meet on May 19 to consider a share buyback. The rally also drew steam from its plan to acquire US-based Assertio in a deal valued at about $166 million. Investors cheered the mix of potential capital return and growth through strategic expansion.

Shares rose about 6% on buyback speculation
Board meeting scheduled for May 19 to consider buyback
Company announced acquisition of US-based Assertio for about $166 million
Market reaction points to optimism on capital return and growth

#stock market #acquisition #share buyback #zydus lifesciences #pharma

Read the full story at The Economic Times

This summarization was done by Beige for a story published on The Economic Times

Zydus Lifesciences shares jump 6% as May 19 buyback plan and 166 million Assertio deal surface

The full experience is on mobile.